Primary |
Product Used For Unknown Indication |
40.0% |
Acute Lymphocytic Leukaemia |
20.0% |
Asthma |
20.0% |
Emphysema |
20.0% |
|
Muscle Spasms |
16.7% |
Product Quality Issue |
16.7% |
Product Substitution Issue |
16.7% |
Respiratory Failure |
16.7% |
Therapeutic Response Unexpected With Drug Substitution |
16.7% |
Wheezing |
16.7% |
|
Secondary |
Asthma |
30.8% |
Chronic Obstructive Pulmonary Disease |
20.5% |
Hypertension |
10.3% |
Analgesia |
7.7% |
Deep Vein Thrombosis |
5.1% |
Antifungal Prophylaxis |
2.6% |
Anxiety |
2.6% |
Blood Cholesterol Increased |
2.6% |
Blood Glucose Fluctuation |
2.6% |
Bronchitis |
2.6% |
Hypersensitivity |
2.6% |
Hypothyroidism |
2.6% |
Neuropathy Peripheral |
2.6% |
Pleuritic Pain |
2.6% |
Smoking Cessation Therapy |
2.6% |
|
Septic Shock |
42.9% |
Asthma |
14.3% |
Headache |
14.3% |
Injection Site Haematoma |
14.3% |
Salivary Hypersecretion |
14.3% |
|
Concomitant |
Asthma |
15.3% |
Drug Use For Unknown Indication |
14.7% |
Product Used For Unknown Indication |
9.9% |
Chronic Obstructive Pulmonary Disease |
7.3% |
Smoking Cessation Therapy |
6.3% |
Hypertension |
5.8% |
Pain |
5.7% |
Multiple Myeloma |
4.4% |
Depression |
4.1% |
Gastrooesophageal Reflux Disease |
3.1% |
Hormone Replacement Therapy |
3.1% |
Anxiety |
2.6% |
Bipolar Disorder |
2.6% |
Hypersensitivity |
2.6% |
Rheumatoid Arthritis |
2.5% |
Convulsion |
2.2% |
Premedication |
2.2% |
Diabetes Mellitus |
2.0% |
Hypercalcaemia Of Malignancy |
2.0% |
Blood Cholesterol Increased |
1.9% |
|
Weight Decreased |
15.5% |
Vomiting |
8.2% |
Vision Blurred |
7.2% |
Nausea |
5.2% |
Pneumonia |
5.2% |
Sleep Disorder |
5.2% |
Wrong Technique In Drug Usage Process |
5.2% |
Anxiety |
4.1% |
Breast Cancer Female |
4.1% |
Diverticular Perforation |
4.1% |
Drug Ineffective |
4.1% |
Fall |
4.1% |
Oedema Peripheral |
4.1% |
Oesophageal Spasm |
4.1% |
Rash |
4.1% |
Abdominal Discomfort |
3.1% |
Asthma |
3.1% |
Chest Discomfort |
3.1% |
Death |
3.1% |
Diverticulitis |
3.1% |
|